[go: up one dir, main page]

CN115198006A - An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection - Google Patents

An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection Download PDF

Info

Publication number
CN115198006A
CN115198006A CN202210854682.7A CN202210854682A CN115198006A CN 115198006 A CN115198006 A CN 115198006A CN 202210854682 A CN202210854682 A CN 202210854682A CN 115198006 A CN115198006 A CN 115198006A
Authority
CN
China
Prior art keywords
sample
gene mutation
crna
rna
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210854682.7A
Other languages
Chinese (zh)
Inventor
李建平
周涛
高智勇
何奕辉
张爱国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Diji Biotechnology Co ltd
Original Assignee
Nanjing Diji Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Diji Biotechnology Co ltd filed Critical Nanjing Diji Biotechnology Co ltd
Priority to CN202210854682.7A priority Critical patent/CN115198006A/en
Publication of CN115198006A publication Critical patent/CN115198006A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明涉及微生物技术领域,具体涉及一种XNA分子钳‑多重荧光PCR法基因突变检测方法;包括制备待测样品;提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果,该方法引入多重荧光PCR扩散技术,通过采用特异性引物和探针技术,三色荧光通道检测模式,建立了实时PCR体系,可以同时检测多种融合基因和多种突变基因,具备特异性好,准确率高,快速廉价,解决现有试剂盒对基因突变状态进行检测耗时长的问题。

Figure 202210854682

The invention relates to the technical field of microorganisms, in particular to an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection; comprising preparing a sample to be tested; extracting DNA and RNA in the sample to be tested, and reversing the RNA, The cRNA is obtained, and then the cRNA and the DNA are mixed and subjected to multiple fluorescent PCR diffusion to obtain a fluorescent sample; the fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result. Methods The multiplex fluorescence PCR diffusion technology was introduced, and the real-time PCR system was established by using specific primer and probe technology and three-color fluorescence channel detection mode, which could detect multiple fusion genes and multiple mutant genes at the same time, with good specificity and accuracy. It has high rate, fast and cheap, and solves the problem of time-consuming detection of gene mutation status by existing kits.

Figure 202210854682

Description

一种XNA分子钳-多重荧光PCR法基因突变检测方法An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection

技术领域technical field

本发明涉及微生物技术领域,尤其涉及一种XNA分子钳-多重荧光PCR法基因突变检测方法。The invention relates to the technical field of microorganisms, in particular to an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection.

背景技术Background technique

肺癌是严重危害人类健康的常见恶性肿瘤之一,其中80~85%的肺癌为非小细胞肺癌。非小细胞肺癌患者中存在多种基因突变类型,其中EGFR、HER2、KRAS、BRAF基因突变频率分别约为10~50%、1~4%、5~25%、1~2%,ALK、ROS1、RET、NTRK1、NTRK2、NTRK3基因融合发生频率分别约为3~7%、1%、1%、0.12%、0.02%、0.08%,MET外显子14跳跃基因突变发生频率约为1%。大量临床研究表明,驱动基因突变状态是靶向药物治疗的重要疗效预测因子,在进行靶向治疗前需要对基因突变状态进行检测,并强烈建议进行更广泛的有效基因的状态检测,因此,对非小细胞肺癌患者的多基因突变联合检测可为患者提供更精准的治疗。Lung cancer is one of the common malignant tumors that seriously endanger human health, and 80-85% of lung cancers are non-small cell lung cancers. There are various types of gene mutation in patients with non-small cell lung cancer, among which the mutation frequency of EGFR, HER2, KRAS, BRAF gene is about 10-50%, 1-4%, 5-25%, 1-2%, ALK, ROS1 , RET, NTRK1, NTRK2, NTRK3 gene fusion frequency is about 3-7%, 1%, 1%, 0.12%, 0.02%, 0.08%, MET exon 14 skip gene mutation frequency is about 1%. A large number of clinical studies have shown that the driver gene mutation status is an important predictor of the efficacy of targeted drug therapy, and it is necessary to detect the gene mutation status before targeted therapy. Combined detection of multiple gene mutations in patients with non-small cell lung cancer can provide patients with more precise treatment.

XNA分子钳是一种新型的核酸分子低聚体,与靶DNA序列杂交,可作为实时定量聚合酶链反应中的分子钳,XNA分子钳检测可以使用液体活检和FFPE样本产生高灵敏度的结果。XNA molecular clamp is a novel nucleic acid molecule oligomer that hybridizes to target DNA sequences and can be used as a molecular clamp in real-time quantitative polymerase chain reaction. The XNA molecular clamp assay can produce highly sensitive results using liquid biopsy and FFPE samples.

这些基因突变或融合状态与靶向药物的疗效相关,然而,目前大多数试剂盒每次只能检测一种或几种基因突变,检测通量低,耗时长,对样本需求量大。These gene mutations or fusion states are related to the efficacy of targeted drugs. However, most of the current kits can only detect one or several gene mutations at a time. The detection throughput is low, time-consuming and requires a large amount of samples.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种XNA分子钳-多重荧光PCR法基因突变检测方法,解决现有试剂盒对基因突变状态进行检测耗时长的问题。The purpose of the present invention is to provide an XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection method, which solves the problem that the detection of gene mutation status takes a long time in the existing kits.

为实现上述目的,本发明提供了一种XNA分子钳-多重荧光PCR法基因突变检测方法:To achieve the above purpose, the present invention provides an XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection:

制备待测样品;prepare samples to be tested;

提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;Extracting the DNA and RNA in the sample to be tested, and reversing the RNA to obtain cRNA, then mixing the cRNA and the DNA and performing multiple fluorescence PCR diffusion to obtain a fluorescent sample;

通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果。The fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result.

其中,所述制备待测样品的具体方式:Wherein, the specific way of preparing the sample to be tested:

将各个来源于无肺病病史健康人群唾液与粪便样本均接种于培养基中,37℃静置厌氧培养20-40h;All saliva and fecal samples from healthy people with no history of lung disease were inoculated into the culture medium, and cultured at 37°C for 20-40h anaerobic;

分别取各个所述培养基中的培养液4ml进行离心,5500rpm,10min,离心后的菌体用pH为6.8的无菌生理盐水洗涤,洗涤后再次进行离心,5500rpm,10min,得到无菌纯水悬浮菌体;Take 4ml of the culture solution in each of the culture medium and centrifuge, 5500rpm, 10min, the thalline after centrifugation is washed with sterile physiological saline with pH 6.8, and centrifuge again after washing, 5500rpm, 10min to obtain sterile pure water suspended bacteria;

将400uL的所述无菌纯水悬浮菌体,沸水浴10min,10000rpm离心15min,收集上清液。Suspend the bacterial cells in 400 uL of the sterile pure water, take a boiling water bath for 10 minutes, centrifuge at 10,000 rpm for 15 minutes, and collect the supernatant.

其中,提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品的具体方式:The specific method of extracting the DNA and RNA in the sample to be tested, and reversing the RNA to obtain cRNA, and then mixing the cRNA and the DNA to perform multiple fluorescence PCR diffusion to obtain a fluorescent sample:

提取所述待测样品中的DNA和RNA,往提取到的所述RNA加热入逆转录反应液,所述RNA与所述逆转录反应液中的逆转录酶混合,得到cRNA;Extracting DNA and RNA in the sample to be tested, heating the extracted RNA into a reverse transcription reaction solution, and mixing the RNA with the reverse transcriptase in the reverse transcription reaction solution to obtain cRNA;

将所述DNA和所述cRNA分别与混合酶混合,并对混合的所述DNA和所述cRNA进行多重荧光PCR扩散,得到所述荧光样品。The DNA and the cRNA are respectively mixed with a mixed enzyme, and the mixed DNA and the cRNA are subjected to multiplex fluorescence PCR diffusion to obtain the fluorescent sample.

其中,所述PCR扩增的反应条件为94℃预变性3min,94℃变性10S,55℃退火30S,72℃延伸90S,整个体系做28个循环,72℃后延伸5min。The reaction conditions of the PCR amplification were pre-denaturation at 94°C for 3 min, denaturation at 94°C for 10S, annealing at 55°C for 30S, extension at 72°C for 90S, the entire system was performed for 28 cycles, and extension at 72°C for 5 min.

其中,所述荧光PCR扩增仪包括壳体、扩增仪本体、调温板和放置组件,所述扩增仪本体与所述壳体固定连接,且位于所述壳体内,所述调温板设置于所述壳体内,所述放置组件设置于所述调温板远离所述扩增仪本体一侧。Wherein, the fluorescent PCR amplifier includes a casing, an amplifier body, a temperature regulation plate and a placement component, the amplifier body is fixedly connected to the casing, and is located in the casing, and the temperature regulation The plate is arranged in the casing, and the placing component is arranged on the side of the temperature regulation plate away from the body of the amplification instrument.

其中,所述放置组件包括放置板、顶杆、固定杆和滑块,所述顶杆设置于所述壳体靠近所述扩增仪本体一侧,所述放置板与所述壳体滑动连接,且位于所述壳体内,所述壳体具有卡槽,所述放置板具有滑槽,所述固定杆设置于所述滑槽内,所述滑块与所述固定杆固定连接,并贯穿所述放置板。Wherein, the placing assembly includes a placing plate, a push rod, a fixing rod and a slider, the push rod is disposed on the side of the casing close to the amplification instrument body, and the placing plate is slidably connected to the casing , and is located in the housing, the housing has a slot, the placement plate has a chute, the fixing rod is arranged in the chute, the slider is fixedly connected with the fixing rod, and penetrates through the the placement plate.

其中,所述固定杆包括滑杆和第一弹簧,所述滑杆与所述放置板滑动连接,且位于所述滑槽内,所述第一弹簧与所述滑杆固定连接,并与所述放置板固定连接,且位于所述滑杆和所述放置板之间。Wherein, the fixing rod includes a sliding rod and a first spring, the sliding rod is slidably connected with the placing plate and is located in the sliding groove, the first spring is fixedly connected with the sliding rod, and is connected with the The placing plate is fixedly connected and located between the sliding rod and the placing plate.

本发明的一种XNA分子钳-多重荧光PCR法基因突变检测方法,制备待测样品;提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;通过荧光PCR扩增仪检测所述荧光样品,并显示所述荧光样品的ct值判定检测结果,该方法引入多重荧光PCR扩散技术,通过采用特异性引物和探针技术,三色荧光通道检测模式,建立了实时PCR体系,可以同时检测多种融合基因和多种突变基因,具备特异性好,准确率高,快速廉价,解决现有试剂盒对基因突变状态进行检测耗时长的问题。A method for detecting gene mutation by XNA molecular clamp-multiplex fluorescence PCR method of the present invention prepares a sample to be tested; extracts DNA and RNA in the sample to be tested, and reverses the RNA to obtain cRNA, and then the After the cRNA and the DNA are mixed, multiplex fluorescent PCR diffusion is performed to obtain a fluorescent sample; the fluorescent sample is detected by a fluorescent PCR amplifier, and the ct value of the fluorescent sample is displayed to determine the detection result. This method introduces the multiple fluorescent PCR diffusion technology , By using specific primers and probe technology, three-color fluorescence channel detection mode, a real-time PCR system has been established, which can detect multiple fusion genes and multiple mutant genes at the same time, with good specificity, high accuracy, fast and cheap, and the solution The detection of gene mutation status by existing kits is time-consuming.

附图说明Description of drawings

为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to these drawings without creative efforts.

图1是本发明提供的一种XNA分子钳-多重荧光PCR法基因突变检测方法的流程图。FIG. 1 is a flow chart of a method for detecting gene mutation by XNA molecular clamp-multiplex fluorescence PCR method provided by the present invention.

图2是本发明提供的荧光PCR扩增仪的结构示意图。FIG. 2 is a schematic structural diagram of the fluorescence PCR amplifier provided by the present invention.

图3是本发明提供的荧光PCR扩增仪的的内部剖视图。FIG. 3 is an internal cross-sectional view of the fluorescence PCR amplifier provided by the present invention.

图中:1-壳体、2-卡槽、3-扩增仪本体、4-调温板、5-放置板、6-滑槽、7-滑杆、8-第一弹簧、9-滑块本体、10-拉杆、11-伸缩杆、12-第二弹簧。In the picture: 1-shell, 2-card slot, 3-amplifier body, 4-thermostat plate, 5-placement plate, 6-chute, 7-slide bar, 8-first spring, 9-slider Block body, 10-draw rod, 11- telescopic rod, 12-second spring.

具体实施方式Detailed ways

下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。The following describes in detail the embodiments of the present invention, examples of which are illustrated in the accompanying drawings, wherein the same or similar reference numerals refer to the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are exemplary, and are intended to explain the present invention and should not be construed as limiting the present invention.

请参阅图1至图3,本发明提供一种XNA分子钳-多重荧光PCR法基因突变检测方法,包括以下步骤:Please refer to FIG. 1 to FIG. 3 , the present invention provides an XNA molecular clamp-multiplex fluorescence PCR method for gene mutation detection, comprising the following steps:

S1制备待测样品;S1 prepares the sample to be tested;

具体方式:Specific way:

S11将各个来源于无肺病病史健康人群唾液与粪便样本均接种于培养基中,37℃静置厌氧培养20-40h;S11 Inoculate saliva and feces samples from healthy people with no history of lung disease into culture medium, and inoculate anaerobic culture at 37°C for 20-40h;

S12分别取各个所述培养基中的培养液4ml进行离心,5500rpm,10min,离心后的菌体用pH为6.8的无菌生理盐水洗涤,洗涤后再次进行离心,5500rpm,10min,得到无菌纯水悬浮菌体;S12 respectively take 4 ml of the culture liquid in each of the medium and centrifuge, 5500rpm, 10min, after the centrifugation, the cells are washed with sterile physiological saline with pH 6.8, and centrifuged again after washing, 5500rpm, 10min, to obtain sterile pure water suspension bacteria;

S13将400uL的所述无菌纯水悬浮菌体,沸水浴10min,10000rpm离心15min,收集上清液。S13 Suspend the bacterial cells in 400 uL of the sterile pure water, take a boiling water bath for 10 minutes, centrifuge at 10,000 rpm for 15 minutes, and collect the supernatant.

S2提取所述待测样品中的DNA和RNA,并将所述RNA逆转处理,得到cRNA,再将所述cRNA和所述DNA混合后进行多重荧光PCR扩散,得到荧光样品;S2 extracts the DNA and RNA in the sample to be tested, and reverses the RNA to obtain cRNA, and then mixes the cRNA and the DNA and performs multiple fluorescence PCR diffusion to obtain a fluorescent sample;

具体的,所述PCR扩增的反应条件为94℃预变性3min,94℃变性10S,55℃退火30S,72℃延伸90S,整个体系做28个循环,72℃后延伸5min,所述PCR扩增反应体系为:2×TaqPCR mix 10μL,DDH2O 9μL,上游引物F1 0.4μL,下游引物R1 0.4μL和样本模板0.2μL,漩涡混匀后闪离5s,置于PCR核酸扩增仪上反应。Specifically, the reaction conditions of the PCR amplification are as follows: pre-denaturation at 94°C for 3 min, denaturation at 94°C for 10S, annealing at 55°C for 30S, extension at 72°C for 90S, the whole system is performed for 28 cycles, and extension at 72°C for 5 min. The amplification reaction system is: 2×TaqPCR mix 10 μL, DDH 2 O 9 μL, upstream primer F1 0.4 μL, downstream primer R1 0.4 μL and sample template 0.2 μL, vortex mixing, flash off for 5 s, and place on PCR nucleic acid amplifier for reaction .

具体方式:Specific way:

S21提取所述待测样品中的DNA和RNA,往提取到的所述RNA加热入逆转录反应液,所述RNA与所述逆转录反应液中的逆转录酶混合,得到cRNA;S21 extracts DNA and RNA in the test sample, heats the extracted RNA into a reverse transcription reaction solution, and mixes the RNA with the reverse transcriptase in the reverse transcription reaction solution to obtain cRNA;

S22将所述DNA和所述cRNA分别与混合酶混合,并对混合的所述DNA和所述cRNA进行多重荧光PCR扩散,得到所述荧光样品。S22 The DNA and the cRNA are mixed with a mixed enzyme, respectively, and the mixed DNA and the cRNA are subjected to multiplex fluorescence PCR diffusion to obtain the fluorescent sample.

S3通过荧光PCR扩增仪检测所述荧光样品,并显示的ct值判定检测结果。S3 detects the fluorescent sample by a fluorescent PCR amplifier, and the displayed ct value determines the detection result.

具体的,利用特异性引物和探针进行PCR反应,突变由FAM/ROX/CY5信号指示,内控由VIC信号指示,通过计算△ct值的大小进行判断,反应管的△ct值≤cut off值时,则样本为该反应管对应信号突变阳性,反之则为阴性或低于试剂盒的检测下线。△ct值=ct值突变位点-ct值内控。Specifically, specific primers and probes are used for PCR reaction, the mutation is indicated by the FAM/ROX/CY5 signal, and the internal control is indicated by the VIC signal. The Δct value of the reaction tube is judged by calculating the Δct value ≤ cut off value. When the sample is positive for the corresponding signal mutation of the reaction tube, it is negative or lower than the detection limit of the kit. Δct value = ct value mutation site - ct value internal control.

进一步的,所述荧光PCR扩增仪包括壳体1、扩增仪本体3、调温板4和放置组件,所述扩增仪本体3与所述壳体1固定连接,且位于所述壳体1内,所述调温板4设置于所述壳体1内,所述放置组件设置于所述调温板4远离所述扩增仪本体3一侧;所述放置组件包括放置板5、顶杆、固定杆和滑块,所述顶杆设置于所述壳体1靠近所述扩增仪本体3一侧,所述放置板5与所述壳体1滑动连接,且位于所述壳体1内,所述壳体1具有卡槽2,所述放置板5具有滑槽6,所述固定杆设置于所述滑槽6内,所述滑块与所述固定杆固定连接,并贯穿所述放置板5;所述固定杆包括滑杆7和第一弹簧8,所述滑杆7与所述放置板5滑动连接,且位于所述滑槽6内,所述第一弹簧8与所述滑杆7固定连接,并与所述放置板5固定连接,且位于所述滑杆7和所述放置板5之间。Further, the fluorescent PCR amplification instrument includes a housing 1, a amplification instrument body 3, a temperature regulating plate 4 and a placement component, and the amplification instrument body 3 is fixedly connected with the housing 1 and is located in the housing. Inside the body 1 , the temperature regulating plate 4 is arranged in the casing 1 , and the placing component is arranged on the side of the temperature regulating plate 4 away from the amplification instrument body 3 ; the placing component includes a placing plate 5 , a mandrel, a fixing rod and a slider, the mandrel is arranged on the side of the housing 1 close to the amplification instrument body 3, the placing plate 5 is slidably connected with the housing 1, and is located in the Inside the casing 1, the casing 1 has a card slot 2, the placing plate 5 has a sliding groove 6, the fixing rod is arranged in the sliding groove 6, and the sliding block is fixedly connected with the fixing rod, and pass through the placing plate 5; the fixing rod includes a sliding rod 7 and a first spring 8, the sliding rod 7 is slidably connected with the placing plate 5, and is located in the sliding groove 6, the first spring 8 is fixedly connected with the sliding bar 7 and fixedly connected with the placing plate 5 , and is located between the sliding bar 7 and the placing plate 5 .

在本实施方式中,所述壳体1对所述扩增仪本体3、所述调温板4和所述放置组件提供安装条件,所述扩增仪本体3利用聚合酶链反应技术对所述DNA和所述cRNA进行扩增,所述调温板4连接冷却液源和热水源,对装有所述DNA和所述cRNA的试管进行加热和冷却,所述放置板5用于放置装有所述DNA和所述cRNA的试管,可同时放置多个试管进行检测,往所述壳体1内放置试管时,将试管放入所述放置板5内,检测员利用手部向中间拉动所述滑块,所述滑块滑动将所述固定杆收入所述放置板5内,检测员再并将所述放置板5放入所述壳体1内,松开所述滑块并下压所述放置板5,使所述放置板5在所述壳体1内滑动挤压所述顶杆,待所述滑槽6和所述卡槽2处于同一水平面时,所述第一弹簧8推动所述滑杆7滑出所述滑槽6,所述滑杆7插入所述卡槽2内,从而将所述放置板5固定,从所述壳体1内取出试管时,检测员再次向中间滑动所述滑块,所述滑块滑动使得所述滑杆7缩回所述滑槽6,将所述滑杆7与所述壳体1分开,所述顶杆复位将所述放置板5顶起,便于检测员将所述放置板5从所述壳体1内取出。In this embodiment, the housing 1 provides installation conditions for the thermal cycler body 3 , the temperature regulation plate 4 and the placement assembly, and the thermal cycler body 3 uses polymerase chain reaction technology to The DNA and the cRNA are amplified, the temperature regulating plate 4 is connected to a cooling liquid source and a hot water source, and the test tube containing the DNA and the cRNA is heated and cooled, and the placement plate 5 is used to place the device. The test tube with the DNA and the cRNA can be placed in multiple test tubes at the same time for detection. When placing the test tube in the housing 1, the test tube is placed in the placement plate 5, and the inspector uses his hand to pull it to the middle The sliding block, the sliding block slides the fixing rod into the placing plate 5, the inspector puts the placing plate 5 into the casing 1, loosens the sliding block and lowers it down. Press the placing plate 5 so that the placing plate 5 slides in the housing 1 and squeezes the ejector rod. When the sliding slot 6 and the card slot 2 are at the same level, the first spring 8 Push the slide bar 7 to slide out of the chute 6, and insert the slide bar 7 into the card slot 2 to fix the placing plate 5. When taking out the test tube from the housing 1, the inspector Slide the slider to the middle again, the slider slides so that the sliding rod 7 retracts into the chute 6, separates the sliding rod 7 from the housing 1, and the top rod is reset to remove the The placing plate 5 is lifted up, which is convenient for the inspector to take out the placing plate 5 from the housing 1 .

进一步的,所述滑块包括滑块本体9和拉杆10,所述滑块本体9与所述滑杆7固定连接,且贯穿所述放置板5,所述拉杆10与所述滑块本体9固定连接,且位于所述滑块本体9一侧。Further, the slider includes a slider body 9 and a pull rod 10 . The slider body 9 is fixedly connected to the slider rod 7 and penetrates through the placing plate 5 . The pull rod 10 is connected to the slider body 9 . It is fixedly connected and located on one side of the slider body 9 .

在本实施方式中,所述拉杆10的设置,便于检测员滑动所述滑块本体9,所述滑块本体9滑动控制所述滑杆7的滑动。In this embodiment, the setting of the pull rod 10 is convenient for the inspector to slide the slider body 9 , and the slider body 9 slides to control the sliding of the sliding rod 7 .

进一步的,所述顶杆包括伸缩杆11和第二弹簧12,所述伸缩杆11与所述壳体1固定连接,且位于靠近所述扩增仪本体3一侧,所述第二弹簧12套设于所述伸缩杆11上。Further, the top rod includes a telescopic rod 11 and a second spring 12. The telescopic rod 11 is fixedly connected to the housing 1 and is located on the side close to the amplification instrument body 3. The second spring 12 It is sleeved on the telescopic rod 11 .

在本实施方式中,所述放置板5下压时,所述放置板5推动所述伸缩杆11,使得所述伸缩杆11和所述第二弹簧12压缩,取出试管时,所述滑杆7与所述壳体1分开,所述第二弹簧12复位带动所述伸缩杆11伸长,从而将所述放置板5顶起。In this embodiment, when the placing plate 5 is pressed down, the placing plate 5 pushes the telescopic rod 11 so that the telescopic rod 11 and the second spring 12 are compressed, and when the test tube is taken out, the sliding rod 7 is separated from the housing 1, and the second spring 12 resets and drives the telescopic rod 11 to extend, so as to lift the placing plate 5.

以上所揭露的仅为本发明一种较佳实施例而已,当然不能以此来限定本发明之权利范围,本领域普通技术人员可以理解实现上述实施例的全部或部分流程,并依本发明权利要求所作的等同变化,仍属于发明所涵盖的范围。The above disclosure is only a preferred embodiment of the present invention, and of course, it cannot limit the scope of rights of the present invention. Those of ordinary skill in the art can understand that all or part of the process for realizing the above-mentioned embodiment can be realized according to the rights of the present invention. The equivalent changes required to be made still belong to the scope covered by the invention.

Claims (7)

1. A gene mutation detection method by an XNA molecular clamp-multiplex fluorescence PCR method is characterized by comprising the following steps:
preparing a sample to be detected;
extracting DNA and RNA in the sample to be detected, reversing the RNA to obtain cRNA, mixing the cRNA with the DNA, and performing multiple fluorescence PCR diffusion to obtain a fluorescence sample;
and detecting the fluorescent sample by a fluorescent PCR (polymerase chain reaction) amplification instrument, and displaying the ct value of the fluorescent sample to judge the detection result.
2. The method of claim 1, wherein the gene mutation is detected by the XNA molecular clamp-multiplex fluorescence PCR method,
the specific mode for preparing the sample to be detected is as follows:
inoculating saliva and feces samples of healthy people with no lung disease history into a culture medium, standing at 37 ℃ and carrying out anaerobic culture for 20-40h;
centrifuging 4ml of culture solution in each culture medium at 5500rpm for 10min, washing the centrifuged thallus with sterile physiological saline with the pH of 6.8, centrifuging again at 5500rpm for 10min to obtain sterile pure water suspended thallus;
400uL of the sterile pure water was suspended in the cells, centrifuged in boiling water bath for 10min and 10000rpm for 15min, and the supernatant was collected.
3. The method for detecting gene mutation by XNA molecular clamp-multiplex fluorescence PCR method as claimed in claim 1,
the specific mode of extracting DNA and RNA in the sample to be detected, reversing the RNA to obtain cRNA, mixing the cRNA with the DNA, and performing multiple fluorescence PCR diffusion to obtain a fluorescence sample is as follows:
extracting DNA and RNA in the sample to be detected, heating the extracted RNA into a reverse transcription reaction solution, and mixing the RNA with reverse transcriptase in the reverse transcription reaction solution to obtain cRNA;
and respectively mixing the DNA and the cRNA with mixed enzyme, and performing multiplex fluorescence PCR diffusion on the mixed DNA and the mixed cRNA to obtain the fluorescence sample.
4. The method of claim 1, wherein the gene mutation is detected by the XNA molecular clamp-multiplex fluorescence PCR method,
the reaction conditions of PCR amplification are pre-denaturation at 94 ℃ for 3min, denaturation at 94 ℃ for 10S, annealing at 55 ℃ for 30S and extension at 72 ℃ for 90S, the whole system is subjected to 28 cycles, and extension is carried out for 5min at 72 ℃.
5. The method of claim 1, wherein the gene mutation is detected by the XNA molecular clamp-multiplex fluorescence PCR method,
fluorescence PCR amplifys appearance includes casing, amplifys appearance body, temperature regulating plate and places the subassembly, the amplifys appearance body with casing fixed connection, and be located in the casing, the temperature regulating plate set up in the casing, place the subassembly set up in the temperature regulating plate is kept away from amplifys appearance body one side.
6. The method of claim 5, wherein the gene mutation is detected by multiplex fluorescence PCR using molecular tweezer-multiplex fluorescence PCR,
the placing assembly comprises a placing plate, an ejector rod, a fixed rod and a sliding block, the ejector rod is arranged on one side, close to the amplification instrument body, of the shell, the placing plate is connected with the shell in a sliding mode and located in the shell, the shell is provided with a clamping groove, the placing plate is provided with a sliding groove, the fixed rod is arranged in the sliding groove, and the sliding block is fixedly connected with the fixed rod and penetrates through the placing plate.
7. The method of claim 6, wherein the gene mutation is detected by the XNA molecular clamp-multiplex fluorescence PCR method,
the fixed rod comprises a sliding rod and a first spring, the sliding rod is connected with the placing plate in a sliding mode and located in the sliding groove, and the first spring is fixedly connected with the sliding rod, fixedly connected with the placing plate and located between the sliding rod and the placing plate.
CN202210854682.7A 2022-07-18 2022-07-18 An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection Pending CN115198006A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210854682.7A CN115198006A (en) 2022-07-18 2022-07-18 An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210854682.7A CN115198006A (en) 2022-07-18 2022-07-18 An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection

Publications (1)

Publication Number Publication Date
CN115198006A true CN115198006A (en) 2022-10-18

Family

ID=83582480

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210854682.7A Pending CN115198006A (en) 2022-07-18 2022-07-18 An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection

Country Status (1)

Country Link
CN (1) CN115198006A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109996891A (en) * 2017-01-05 2019-07-09 南京帝基生物科技有限公司 Methods for early detection of colon cancer and/or colon cancer precursor cells and for monitoring colon cancer recurrence
CN111235272A (en) * 2020-01-10 2020-06-05 厦门艾德生物医药科技股份有限公司 Composition for one-time detection of lung cancer multiple gene mutation and application thereof
CN214781781U (en) * 2021-06-02 2021-11-19 天津海关动植物与食品检测中心 PCR augmentor
CN214881408U (en) * 2021-03-31 2021-11-26 河南省依斯特检测技术有限公司 PCR amplification instrument with adjustable sample rack
CN215250734U (en) * 2021-02-26 2021-12-21 上海完形健康管理咨询有限公司 MicroRNA quantitative determination kit

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109996891A (en) * 2017-01-05 2019-07-09 南京帝基生物科技有限公司 Methods for early detection of colon cancer and/or colon cancer precursor cells and for monitoring colon cancer recurrence
CN111235272A (en) * 2020-01-10 2020-06-05 厦门艾德生物医药科技股份有限公司 Composition for one-time detection of lung cancer multiple gene mutation and application thereof
CN215250734U (en) * 2021-02-26 2021-12-21 上海完形健康管理咨询有限公司 MicroRNA quantitative determination kit
CN214881408U (en) * 2021-03-31 2021-11-26 河南省依斯特检测技术有限公司 PCR amplification instrument with adjustable sample rack
CN214781781U (en) * 2021-06-02 2021-11-19 天津海关动植物与食品检测中心 PCR augmentor

Similar Documents

Publication Publication Date Title
CN110229908A (en) Primer, probe and kit for early detection change gene methylation level in lung cancer
CN118291632A (en) Primer probe composition for early screening of bladder cancer, kit and application
CN112609002B (en) Peripheral blood miRNA colon cancer diagnosis marker combination and detection kit thereof
CN113652490A (en) Primer probe combination and kit for early screening and/or prognosis monitoring of bladder cancer
CN114959030B (en) Application of reagent for detecting HCG9 gene methylation in preparation of product for diagnosing bladder cancer
CN113621704B (en) Reagent and kit for detecting and diagnosing liver cancer
CN110484625A (en) For detecting primer combination of probe object, kit and the detection method of PRKY gene methylation
CN115198006A (en) An XNA molecular clamp-multiplex fluorescent PCR method for gene mutation detection
CN108796078B (en) Primer and probe set for diagnosing, detecting or screening digestive tract cancer
CN118834956A (en) Primer and probe combination, kit and use thereof in detecting EMX1 and CHFR gene methylation
CN117248021A (en) Nucleic acid combination, kit and application for detecting urothelial cancer or precancerous lesions
CN113862370B (en) Primer, probe and kit for screening liver cancer and application of kit
CN115927610B (en) Application of reagents for detecting methylation levels of target regions in the FOXO6 gene in the preparation of bladder cancer diagnostic products
CN118147298A (en) Application of reagent for detecting methylation level in preparation of head and neck squamous cell carcinoma diagnostic product
CN116716408A (en) DNA methylation composition for detecting benign and malignant lung nodules, kit and application
CN115851941A (en) Marker, nucleic acid product and kit for screening esophageal cancer and application of marker and kit
CN116676405A (en) Primer group for detecting nocardia bacteria and application thereof
CN102399858A (en) DNA point mutation detection method based on fluorescence quenching relief
CN116103411A (en) Primer probe composition and kit for detecting helicobacter pylori drug-resistant gene mutation in sample
WO2024036785A1 (en) Dna methylation marker combination for early screening of gastric cancer and kit
CN116004831A (en) Reagent for diagnosing or assisting in diagnosing bladder cancer and detection kit
CN107177688A (en) The kit of the deaf susceptibility gene mutation of detection and its application
CN113684279A (en) Primer group, kit and detection method for diagnosing osteosarcoma
CN114381519A (en) Serum miRNA marker combination for breast cancer auxiliary diagnosis and detection kit thereof
CN116162707B (en) New application of reagent for detecting methylation level of target region in CYTH gene or/and SIX3 gene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination